Clinical Trial Update: A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating autologous tumor-infiltrating lymphocytes (TIL) therapy in solid tumors, including nasopharyngeal carcinoma, hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hepatocellular Carcinoma
• Nasopharyngeal Carcinoma

Drugs mentioned

• Autologous tumor-infiltrating lymphocytes (TIL) therapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Hepatocellular Carcinoma | Phase 1 | Status: UNKNOWN